New advancements in artificial intelligence have the capacity to deliver major breakthroughs in cancer therapy.
AI-powered protein design company Profluent used AI to make an open-source gene editor called OpenCRISPR-1.
OpenCRISPR-1 can create molecules with the power to edit the human genome, according to Profluent.
Profluent’s aim is to develop gene editors that are more operative than existing biological mechanisms, especially mechanisms that prevent illnesses like cancer and fight viruses.
AI presenter Priya Lakhani joins The Context to explain this development in health and technology.
Subscribe here: http://bit.ly/1rbfUog
For more news, analysis and features visit: www.bbc.com/news
#Technology #Health #BBCNews
Public attitudes to immigration are hardening in the Irish Republic as the country sees a significant increase in arrivals. The…
L'edizione della notte del Tg diretto da Enrico Mentana
L'informazione della testata giornalistica di LA7 diretta da Enrico Mentana
ROMA (ITALPRESS) – La Lazio stende 3-0 il Bologna nel match dell’Olimpico e centra la sua settima vittoria consecutiva: decidono…
NAPOLI (ITALPRESS) – Non riesce il colpaccio alla nuova Roma di Claudio Ranieri, che al “Maradona” gioca una partita tutto…
MALAGA (SPAGNA) (ITALPRESS) – Altro successo, altro trionfo, targato Jannik Sinner. L’annata straordinaria del tennis italiano non poteva chiudersi in…